Cremers S

ORCID: 0000-0002-6800-5532 · 3 papers in corpus
review 2019
British journal of clinical pharmacology ·doi:10.1111/bcp.13881

Mathematical modelling and simulation (M&S) of drug concentrations, pharmacologic effects and the (patho)physiologic systems within which they interact can be powerful tools for the preclinical, translational and clinical development of dru…

nonrandomized-trial 2015
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-2829

CONTEXT: Without antiresorptive therapy, postmenopausal women lose bone mass after teriparatide (TPTD) discontinuation; estrogen treatment prevents bone loss in this setting. It is not known whether premenopausal women with regular menses l…

nonrandomized-trial 2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-1172

CONTEXT: Premenopausal women with idiopathic osteoporosis (IOP) have abnormal cortical and trabecular bone microarchitecture. OBJECTIVE: The purpose of this study was to test the hypotheses that teriparatide increases bone mineral density …